Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid LeukemiaBruce D. Cheson, Clara D. Bloomfield, Andrea Biondi et al.|Journal of Clinical Oncology|2003Cited by 2.7k
Diagnostic criteria and classification of mastocytosis: a consensus proposalPeter Valent, John M. Bennett, Hans‐P. Horny et al.|Leukemia Research|2001Cited by 1.1k
Anthracycline Dose Intensification in Acute Myeloid LeukemiaHugo F. Fernández, Martin S. Tallman, Zhuoxin Sun et al.|New England Journal of Medicine|2009Cited by 907
Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromesElsa Bernard, Alexandra Smith, Yasuhito Nannya et al.|Nature Medicine|2020Cited by 633
Benefit of high-dose daunorubicin in AML induction extends across cytogenetic and molecular groupsMarlise R. Luskin, Selina M. Luger, Ju-Whei Lee et al.|Blood|2016Cited by 128